Published in J Clin Oncol on March 10, 2007
Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA (2010) 10.97
Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol (2009) 1.76
Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc (2012) 1.64
Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys (2010) 1.58
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer (2014) 1.55
Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res (2014) 1.43
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiat Oncol (2011) 1.39
Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist (2012) 1.25
Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol (2008) 1.21
Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol (2014) 1.21
Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys (2012) 1.20
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations. Radiat Oncol (2012) 1.12
Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Gastrointest Endosc (2012) 1.10
Cyberknife: A double edged sword? Rep Pract Oncol Radiother (2010) 1.10
Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer (2012) 1.08
Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys (2008) 1.07
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. Radiat Oncol (2013) 1.02
Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions. Radiat Oncol (2009) 1.02
Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer. Radiat Oncol (2013) 0.99
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience. Ann Surg Oncol (2015) 0.97
Stereotactic body radiation therapy (SBRT) for adrenal metastases : a feasibility study of advanced techniques with modulated photons and protons. Strahlenther Onkol (2011) 0.94
Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images. Int J Radiat Oncol Biol Phys (2012) 0.93
Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol (2014) 0.92
Evaluation of the geometric accuracy of surrogate-based gated VMAT using intrafraction kilovoltage x-ray images. Med Phys (2012) 0.91
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial. Target Oncol (2013) 0.91
Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys (2010) 0.91
Review of stereotactic radiosurgery for intramedullary spinal lesions. Korean J Spine (2013) 0.89
The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation. PLoS One (2014) 0.89
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.87
Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report. J Med Case Rep (2009) 0.86
Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer. Breast Care (Basel) (2011) 0.85
In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids. PLoS Comput Biol (2013) 0.84
Frontiers in radiotherapy for early-stage invasive breast cancer. J Clin Oncol (2014) 0.83
Motion management in gastrointestinal cancers. J Gastrointest Oncol (2014) 0.83
Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus (2016) 0.82
Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study. Radiat Oncol (2009) 0.82
Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy. BMC Res Notes (2013) 0.82
Evaluation of pencil beam convolution and anisotropic analytical algorithms in stereotactic lung irradiation. J Med Phys (2011) 0.82
Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis. Biomed Res Int (2014) 0.81
Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer. Front Oncol (2013) 0.80
Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol (2013) 0.79
Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells. Cancer Gene Ther (2008) 0.79
To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer. Radiat Oncol (2016) 0.79
Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy. BMC Med Phys (2008) 0.78
Stereotactic Body Radiation Therapy: A useful weapon in anticancer treatment. Rep Pract Oncol Radiother (2015) 0.77
Improved survival of mice after total body irradiation with 10 MV photon, 2400 MU/min SRS beam. In Vivo (2014) 0.77
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions. Front Oncol (2016) 0.76
Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? Nat Rev Urol (2016) 0.76
Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy. Radiat Res (2016) 0.75
4D radiobiological modelling of the interplay effect in conventionally and hypofractionated lung tumour IMRT. Br J Radiol (2014) 0.75
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response. Br J Radiol (2016) 0.75
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma. Cancers (Basel) (2010) 0.75
Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. Int J Radiat Oncol Biol Phys (2016) 0.75
Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects. BMC Cancer (2014) 0.75
Successful treatment of non-small cell lung tumor with 15 lesions by CyberKnife radiosurgery: A case report. Exp Ther Med (2013) 0.75
A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases. Ann Surg Oncol (2015) 0.75
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget (2016) 0.75
Intravascular Placement of Metallic Coils as Lung Tumor Markers for CyberKnife Stereotactic Radiation Therapy. Korean J Radiol (2015) 0.75
Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther (2015) 0.75
Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice. Rep Pract Oncol Radiother (2017) 0.75
A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys (2017) 0.75
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol (2006) 8.15
SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet (2005) 5.23
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys (2008) 5.03
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol (2009) 4.59
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys (2009) 4.23
Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys (2010) 3.87
Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys (2003) 3.14
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol (2011) 3.12
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol (2009) 3.00
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2009) 2.78
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest (2003) 2.60
Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys (2005) 2.58
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol (2012) 2.47
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys (2005) 2.41
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging (2012) 2.34
Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27
Bridging the gap between IMRT and VMAT: dense angularly sampled and sparse intensity modulated radiation therapy. Med Phys (2011) 2.18
Objective assessment of deformable image registration in radiotherapy: a multi-institution study. Med Phys (2008) 2.15
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 2.14
Four-dimensional cone-beam computed tomography using an on-board imager. Med Phys (2006) 2.08
Evaluation of on-board kV cone beam CT (CBCT)-based dose calculation. Phys Med Biol (2007) 2.02
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
GPU computing in medical physics: a review. Med Phys (2011) 1.85
Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci (2006) 1.80
Iterative image reconstruction for CBCT using edge-preserving prior. Med Phys (2009) 1.80
Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol (2009) 1.76
X-ray luminescence computed tomography via selective excitation: a feasibility study. IEEE Trans Med Imaging (2010) 1.76
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.73
Model-based image reconstruction for four-dimensional PET. Med Phys (2006) 1.71
Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70
Enhanced 4D cone-beam CT with inter-phase motion model. Med Phys (2007) 1.69
Compressed sensing based cone-beam computed tomography reconstruction with a first-order method. Med Phys (2010) 1.68
Noise suppression in scatter correction for cone-beam CT. Med Phys (2009) 1.66
Tomographic molecular imaging of x-ray-excitable nanoparticles. Opt Lett (2010) 1.65
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 1.57
Scatter correction for cone-beam CT in radiation therapy. Med Phys (2009) 1.55
The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol (2007) 1.49
Image interpolation in 4D CT using a BSpline deformable registration model. Int J Radiat Oncol Biol Phys (2006) 1.49
Optimizing 4D cone-beam CT acquisition protocol for external beam radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.46
Dose reduction for kilovotage cone-beam computed tomography in radiation therapy. Phys Med Biol (2008) 1.46
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol (2011) 1.46
OCT assessment of allograft vasculopathy in heart transplant recipients. JACC Cardiovasc Imaging (2012) 1.43
Monte Carlo simulation of the Leksell Gamma Knife: I. Source modelling and calculations in homogeneous media. Phys Med Biol (2002) 1.39
Formulating adaptive radiation therapy (ART) treatment planning into a closed-loop control framework. Phys Med Biol (2007) 1.37
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med (2006) 1.37
Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. J Nucl Med (2012) 1.30
Using total-variation regularization for intensity modulated radiation therapy inverse planning with field-specific numbers of segments. Phys Med Biol (2008) 1.30
Four-dimensional inverse treatment planning with inclusion of implanted fiducials in IMRT segmented fields. Med Phys (2009) 1.29
Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys (2008) 1.29
Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys (2008) 1.26
Segment-based dose optimization using a genetic algorithm. Phys Med Biol (2003) 1.26
Synthesis and radioluminescence of PEGylated Eu(3+) -doped nanophosphors as bioimaging probes. Adv Mater (2011) 1.26
Investigation of X-ray fluorescence computed tomography (XFCT) and K-edge imaging. IEEE Trans Med Imaging (2012) 1.24
Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol (2011) 1.22
Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys (2013) 1.22
First demonstration of multiplexed X-ray fluorescence computed tomography (XFCT) imaging. IEEE Trans Med Imaging (2012) 1.16
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact (2011) 1.16
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys (2010) 1.16
Search for IMRT inverse plans with piecewise constant fluence maps using compressed sensing techniques. Med Phys (2009) 1.16
Multiscale registration of planning CT and daily cone beam CT images for adaptive radiation therapy. Med Phys (2009) 1.15
In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed (2010) 1.15
Feature-based rectal contour propagation from planning CT to cone beam CT. Med Phys (2008) 1.15
Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck (2007) 1.14
High-resolution radioluminescence microscopy of 18F-FDG uptake by reconstructing the β-ionization track. J Nucl Med (2013) 1.12
High density dental materials and radiotherapy planning: comparison of the dose predictions using superposition algorithm and fluence map Monte Carlo method with radiochromic film measurements. Radiother Oncol (2006) 1.11
Image registration with auto-mapped control volumes. Med Phys (2006) 1.11
A fiducial detection algorithm for real-time image guided IMRT based on simultaneous MV and kV imaging. Med Phys (2008) 1.10
Hybrid multiscale landmark and deformable image registration. Math Biosci Eng (2007) 1.10
Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment. Am J Clin Oncol (2009) 1.09
Multiscale deformable registration of noisy medical images. Math Biosci Eng (2008) 1.08
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol (2009) 1.07
Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). Int J Radiat Oncol Biol Phys (2008) 1.07
Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther (2009) 1.06
Radioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cells. PLoS One (2012) 1.06
An adaptive planning strategy for station parameter optimized radiation therapy (SPORT): Segmentally boosted VMAT. Med Phys (2013) 1.05
Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys (2003) 1.05
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park) (2004) 1.05
Reducing respiratory motion artifacts in positron emission tomography through retrospective stacking. Med Phys (2006) 1.04
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol (2006) 1.03
Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging (2012) 1.03
Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys (2005) 1.03
Aperture modulated arc therapy. Phys Med Biol (2003) 1.03
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.02
Metal artifact reduction in x-ray computed tomography (CT) by constrained optimization. Med Phys (2011) 1.02
Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc (2014) 1.01
Dose reconstruction for volumetric modulated arc therapy (VMAT) using cone-beam CT and dynamic log files. Phys Med Biol (2010) 1.01
Predicting respiratory tumor motion with multi-dimensional adaptive filters and support vector regression. Phys Med Biol (2009) 1.00
4D cone beam CT via spatiotemporal tensor framelet. Med Phys (2012) 1.00
Development of XFCT imaging strategy for monitoring the spatial distribution of platinum-based chemodrugs: instrumentation and phantom validation. Med Phys (2013) 1.00
Radiobiological basis of SBRT and SRS. Int J Clin Oncol (2014) 0.99
Improved compressed sensing-based cone-beam CT reconstruction using adaptive prior image constraints. Phys Med Biol (2012) 0.99
Development of a QA phantom and automated analysis tool for geometric quality assurance of on-board MV and kV x-ray imaging systems. Med Phys (2008) 0.99
Feasibility study of beam orientation class-solutions for prostate IMRT. Med Phys (2004) 0.99
Tissue feature-based and segmented deformable image registration for improved modeling of shear movement of lungs. Int J Radiat Oncol Biol Phys (2009) 0.98
Automated contour mapping with a regional deformable model. Int J Radiat Oncol Biol Phys (2008) 0.98
Dynamic-MLC leaf control utilizing on-flight intensity calculations: a robust method for real-time IMRT delivery over moving rigid targets. Med Phys (2007) 0.98
Dose-volume based ranking of incident beam direction and its utility in facilitating IMRT beam placement. Int J Radiat Oncol Biol Phys (2005) 0.98
Multisource modeling of flattening filter free (FFF) beam and the optimization of model parameters. Med Phys (2011) 0.98